Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women Journal Article


Authors: Grant, D. J.; Manichaikul, A.; Alberg, A. J.; Bandera, E. V.; Barnholtz-Sloan, J.; Bondy, M.; Cote, M. L.; Funkhouser, E.; Moorman, P. G.; Peres, L. C.; Peters, E. S.; Schwartz, A. G.; Terry, P. D.; Wang, X. Q.; Keku, T. O.; Hoyo, C.; Berchuck, A.; Sandler, D. P.; Taylor, J. A.; O’Brien, K. M.; Velez Edwards, D. R.; Edwards, T. L.; Beeghly-Fadiel, A.; Wentzensen, N.; Pearce, C. L.; Wu, A. H.; Whittemore, A. S.; McGuire, V.; Sieh, W.; Rothstein, J. H.; Modugno, F.; Ness, R.; Moysich, K.; Rossing, M. A.; Doherty, J. A.; Sellers, T. A.; Permuth-Way, J. B.; Monteiro, A. N.; Levine, D. A.; Setiawan, V. W.; Haiman, C. A.; LeMarchand, L.; Wilkens, L. R.; Karlan, B. Y.; Menon, U.; Ramus, S.; Gayther, S.; Gentry-Maharaj, A.; Terry, K. L.; Cramer, D. W.; Goode, E. L.; Larson, M. C.; Kaufmann, S. H.; Cannioto, R.; Odunsi, K.; Etter, J. L.; Huang, R. Y.; Bernardini, M. Q.; Tone, A. A.; May, T.; Goodman, M. T.; Thompson, P. J.; Carney, M. E.; Tworoger, S. S.; Poole, E. M.; Lambrechts, D.; Vergote, I.; Vanderstichele, A.; Van Nieuwenhuysen, E.; Anton-Culver, H.; Ziogas, A.; Brenton, J. D.; Bjorge, L.; Salvensen, H. B.; Kiemeney, L. A.; Massuger, L. F. A. G.; Pejovic, T.; Bruegl, A.; Moffitt, M.; Cook, L.; Le, N. D.; Brooks-Wilson, A.; Kelemen, L. E.; Pharoah, P. D. P.; Song, H.; Campbell, I.; Eccles, D.; DeFazio, A.; Kennedy, C. J.; Schildkraut, J. M.
Article Title: Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
Abstract: An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom-designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high-grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significance of selected SNPs using the Bayesian False Discovery Probability (BFDP). A significant association with EOC was identified in the UGT2A1/2 region for the SNP rs10017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 1.2 × 10−6, BFDP = 0.02); and an association with HGSOC was identified in the EGFR region for the SNP rs114972508 (per allele OR = 2.3, 95% CI = 1.6-3.4, P = 1.6 × 10−5, BFDP = 0.29) and in the UGT2A1/2 region again for rs1017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 2.3 × 10−5, BFDP = 0.23). Genetic variants in the EGFR and UGT2A1/2 may increase susceptibility of EOC in AA women. Future studies to validate these findings are warranted. Alterations in EGFR and UGT2A1/2 could perturb enzyme efficacy, proliferation in ovaries, impact and mark susceptibility to EOC. © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Keywords: ovarian cancer; genetic association; african ancestry risk; vitamin d pathway
Journal Title: Cancer Medicine
Volume: 8
Issue: 5
ISSN: 2045-7634
Publisher: Wiley Blackwell  
Date Published: 2019-05-01
Start Page: 2503
End Page: 2513
Language: English
DOI: 10.1002/cam4.1996
PUBMED: 31001917
PROVIDER: scopus
PMCID: PMC6536963
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Douglas A Levine
    380 Levine